Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

15:55 EST 1st March 2015 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,300+

Sunday 1st March 2015

Young girl's story may lead Idaho to approve marijuana oil

(AP)—Ten-year-old Alexis Carey has a rare but intractable form of epilepsy, Dravet Syndrome. The genetic diseases causes severe and multiple seizures, which often leave parents guessing if the terror of watching their child seize up will pass or tu...

Crispr Therapeutics

Developing cures for serious human genetic diseases using CRISPR-Cas9 Technology.

Saturday 28th February 2015

Slip Me Some Skin

Scientists tracing the history of livestock breeding probe parchment documents for genetic information.

Wrangling Retrotransposons

These mobile genetic elements can wreak havoc on the genome. Researchers are now trying to understand how such activity contributes to the aging process.

Genetics reveals where emperor penguins survived the last ice age

(University of Southampton) A study of how climate change has affected emperor penguins over the last 30,000 years found that only three populations may have survived during the last ice age, and that the Ross Sea in Antarctica was likely the refuge ...

Fighting Colorado potato beetle with RNA interference -- ScienceDaily

Feeding experiment with different potato leaves: Detached leaves of unmodified plants were compared to plants with an altered chloroplast genome. First instar larvae were fed on these leaves for three days in intervals of 24 hours. The leaves were replaced after each interval.

The Seven Trends That Define The Future of IVF

Your humble columnist, a retired reproductive endocrinologist, suggests the following seven trends that will define in vitro fertilization (IVF) in the coming decade: 1)   IVF for the prevention of disease: The combination of 1) inexpensive human g...

New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients

Carlsbad Eye Care ophthalmologist Dr. Michael Tracy comments on a new gene therapy procedure designed to slow or halt the progression of blindness in patients with choroideremia. Carlsbad, CA (PRWEB) February 28, 2015 A study out of the University of Oxford has developed a promising new gene therapy procedure for the treatment of a hereditary ocular condition that leads to progressive blindness i...

Stimulating the brain can bring relief from pain

Brett Smith for - Your Universe Online Head pounding from that happy hour last night that somehow lasted until 2 am? You can easily solve that problem by sticking a fiber optic wire in your brain and turning on the juice. In a study just published by the journal PLOS ONE, researchers from the University of Texas at Arlington showed how the stimulation of an area the brain called th...

Haplogen – haploid genetics tools

Haplogen is a biotech company constructing next generation haploid genetics tools for target discovery programs. Haplogen also supports experimental human genetics in the wider scientific community, by generating the world’s largest collection of human cell lines with thousands of clones … Continue reading → Cet article Haplogen – haploid genetics tools est apparu en premier su...

Friday 27th February 2015

UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans

Hispanics develop alcoholic liver disease (ALD), a common cause of liver-disease death, between four and 12 years earlier than Whites/Caucasians or African Americans, according to a new study from UC Davis Health System. Sacramento, Calif. (PRWEB) February 27, 2015 Hispanics develop alcoholic liver disease (ALD), a common cause of liver-disease death, between four and 12 years earlier than Whites...

Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available

Beverly Hills rheumatologist, Dr. Susan Baker, has high hopes for a new blood test that will effectively detect early signs of Sjögren’s Syndrome Beverly Hills, CA (PRWEB) February 27, 2015 Just a little over two years ago, hope was in the air for those suffering from Sjögren’s Syndrome after a new autoantibody associated with the disease had been discovered by researchers at the Un...

A new tool provides maps of protein interactions for 2,800 diseases

  SOURCE February 27, 2015 (Nanowerk News) Today in the journal Nature Methods (“dSysMap: exploring the edgetic role of disease mutations”), the laboratory headed by ICREA researcher Patrick Aloy, at the Institute for Research in Biomedicine (IRB Barcelona), presents a computational tool that allows a greater understanding of the genetic […]

Dr. Gregg R. Codelli Now Treats Gum Recession in the Atlanta, GA Area through a Minimally Invasive Gum Graft Alternative

Dr. Gregg R. Codelli has recently become certified to perform the Pinhole Surgical Technique™ for patients in Atlanta, GA who are suffering from gum recession. This minimally invasive gum grafting alternative provides patients with instant, lasting results so they leave Dr. Codelli’s office with a brand new smile. Atlanta, GA (PRWEB) February 27, 2015 Dr. Gregg R. Codelli, a leading periodont...

Zoetis Declares Second Quarter 2015 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2015 dividend payable to holders of the company’s common stock of $0.083 per share. The dividend is to be paid on Tuesday, June 2, 2015, to holders of record on Thursday, April 9, 2015. About Zoetis Zoetis (zô-EH-t

UC Davis Huntington's Disease Center Receives Level 1 Designation

The UC Davis Huntington’s Disease Center, whose compassionate patient care and research expertise have made it a beacon of hope for people with Huntington’s disease throughout Northern California and beyond, has been acknowledged by the national society committed to the values that it so ably upholds the Huntington’s Disease Society of America — as a Level 1 Huntington’s Disease Center o...

FDA gets feedback on next-generation sequencing

As FDA digests comments from last week's next-generation sequencing (NGS) workshop, Elizabeth Mansfield, the deputy office director for personalized medicine at the agency's Center for Devices and Radiological Health (CDRH), told BioCentury it could ...

Untangling DNA with a droplet of water, pipet and polymer

Researchers have long sought an efficient way to untangle DNA in order to study its structure—neatly unraveled and straightened out—under a microscope. Now, chemists and engineers at KU Leuven, in Belgium, have devised a strikingly simple and eff...

Friday Feedback: Do-It-Yourself Genetic Testing

(MedPage Today) -- What will it mean to clinicians when consumers buy genetic tests on their own?


JINARC® (tolvaptan), if approved, will become the first pharmaceutical therapy available in Europe for patients with ADPKD. Tolvaptan, discovered and developed in Japan by Otsuka Pharmaceutical, was first approved there for ADPKD in 2014. It was approved for ADPKD in Canada in February 2015. ADPKD is a chronic and progressi...

Cystic Fibrosis Market in Europe Resorts to Public Awareness Campaigns to Further Growth announces that a new market research report is available in its catalogue: Cystic Fibrosis Market in Europe Albany, NewYork (PRWEB) February 27, 2015 The report ‘Cystic Fibrosis Market in Europe 2015-2019,’ added by ResearchMoz, provides a snapshot of the global market scenario for cystic fibrosis along with an in-depth coverage of the growth prospects, market challenges, marke...

Edimer Pharmaceuticals Celebrates Rare Disease Day 2015 by Initiating Yearlong Series of Regional Conferences for Healthcare Providers and Patients

Series provides opportunity to share experiences and resources, hear the latest research, and receive updates about the ongoing Phase 2 clinical trial of EDI200 in XLHED Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today ann...

Health 2.0 and Mad*Pow Announce Final Agenda For HxRefactored

SAN FRANCISCO, Feb. 27, 2015 /PRNewswire/ -- Health 2.0 and Mad*Pow announce the final agenda for the upcoming HxRefactored Conference, April 1-2 in Boston, Massachusetts. HxRefactored is a revolutionary design and technology conference gathering over 600 designers, developers, and entrepreneurs in health care for two days of thought provoking panels, workshops and discussions on how to im...

INSERTING and REPLACING Transgenomic Announces Pricing of Public Offering of Common Stock

Insert after first paragraph, first sentence: The common stock and corresponding warrants will be sold in combination, with one warrant to purchase 0.20 of a share of common stock for each share of common stock sold. The combined purchase price for each share of common stock and corresponding warrant is $1.95. Insert before second paragraph: The a...

Epizyme to Present at Cowen and Company 35th Annual Health Care Conference

Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation at the Cowen and Company 35th Annual Health Care Conference on Monday, March 2 at 3:30 p.m. ET at the Boston Marriott Copley Place in Boston. ...

Search BioPortfolio:

News Quicklinks